Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2E)-3,3'-dioxo-1,1',3,3'-tetrahydro-2,2'-biindole-5,5'-disulfonate
-
inhibition profile and inhibition of root growth, overview
(5-bromo-2-[[([2-[(2-chloroethoxy)methyl]phenyl]sulfonyl)carbamoyl]amino]pyrimidin-4-yl)methyl benzoate
-
-
(5-bromo-2-[[([2-[(2-chloroethoxy)methyl]phenyl]sulfonyl)carbamoyl]amino]pyrimidin-4-yl)methyl phenylacetate
-
-
(5-bromo-2-[[([2-[(2-chloroethoxy)methyl]phenyl]sulfonyl)carbamoyl]amino]pyrimidin-4-yl)methyl prop-2-enoate
-
-
1-(4,6-dimethoxypyrimidin-2-yl)-5-methoxymethyl-N-(2-isopropyl-6-nitrophenyl)-1H-1,2,4-triazole-3-sulfonamide
-
-
1-(4,6-dimethoxypyrimidin-2-yl)-5-methyl-N-(2-isopropyl-6-nitrophenyl)-1H-1,2,4-triazole-3-sulfonamide
-
-
1-(4,6-dimethoxypyrimidin-2-yl)-5-methylthio-N-(2-chloro-6-fluorophenyl)-1H-1,2,4-triazole-3-sulfonamide
-
-
1-(4-chloro-6-methoxypyrimidin-2-yl)-5-methoxy-N-(2-methyl-6-nitrophenyl)-1H-1,2,4-triazole-3-sulfonamide
-
-
1-methoxy-1-oxopropan-2-yl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methyl[1,1'-biphenyl]-2-carboxylate
-
2'-chloro-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylic acid
-
2,3-dichloro-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-(1,1-dihydroxyethyl)-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-(2,3-dichlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2,3-difluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2,4-dichlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2,4-difluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2,5-dichlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2,5-difluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2-bromo-4-fluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2-bromobenzyl)-8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
2-(2-bromophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2-chloro-4-methylphenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(2-chlorobenzyl)-8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
2-(2-chloroethoxy)-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-(2-chloroethoxy)-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-(2-chlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(3-bromo-4-fluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(3-chlorobenzyl)-8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
2-(3-chlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(3-fluorophenyl)-4-oxoquinazolin-3(4H)-yl 3-(trifluoromethyl)benzoate
-
30% inhibition at 0.1 mM
2-(3-fluorophenyl)-4-oxoquinazolin-3(4H)-yl 3-chlorobenzoate
-
42.5% inhibition at 0.1 mM
2-(3-fluorophenyl)-4-oxoquinazolin-3(4H)-yl 3-fluorobenzoate
-
72% inhibition at 0.1 mM
2-(3-fluorophenyl)-4-oxoquinazolin-3(4H)-yl 3-methoxybenzoate
-
28% inhibition at 0.1 mM
2-(3-fluorophenyl)-4-oxoquinazolin-3(4H)-yl benzoate
-
26% inhibition at 0.1 mM
2-(3-methoxyphenyl)-4-oxoquinazolin-3(4H)-yl 3-(trifluoromethyl)benzoate
-
73.2% inhibition at 0.1 mM
2-(3-methoxyphenyl)-4-oxoquinazolin-3(4H)-yl 3-chlorobenzoate
-
23.5% inhibition at 0.1 mM
2-(3-methoxyphenyl)-4-oxoquinazolin-3(4H)-yl 3-nitrobenzoate
-
94% inhibition at 0.1 mM
2-(4-bromo-3-methylphenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(4-chloro-2-fluorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(4-chloro-2-methylphenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(4-chloro-3-methylphenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(4-chlorobenzyl)-8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
2-(4-chlorophenoxy)-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-(5-chloropyridin-3-yl)-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylbenzoic acid
-
2-(5-ethyl-3-methylpyridin-2-yl)-5-isopropyl-5-methyl-3,5-dihydro-4H-imidazol-4-one
2-(6-chloropyridin-3-yl)-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylbenzoic acid
-
2-(difluoromethoxy)-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-acetyl-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-acetyl-6-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]benzoic acid
-
2-amino-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-bromo-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-bromo-6-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]benzoic acid
-
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-butoxy-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-butyl-8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
2-chloro-3-oxocyclohex-1-en-1-yl 3-(trifluoromethyl)benzoate
-
2-chloro-3-oxocyclohex-1-en-1-yl-3-(trifluoromethyl)benzoate
-
2-chloro-5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-chlorobenzoate
-
2-chloro-5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-chlorobenzoic acid
no inhibition by bensulfuron methyl. Feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern
2-chloro-5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-chlorobenzoic acid ester
-
2-chloro-6-(methoxycarbonyl)-5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-chlorobenzoate
-
2-chloro-6-methoxycarbonyl-5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-chlorobenzoate
-
2-chloro-6-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-chloro-6-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]benzoic acid
-
2-chloro-N-(4-chloro-3-[[(4-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl]phenyl)acetamide
-
2-chloro-N-(4-chloro-3-[[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]phenyl)acetamide
-
2-chloro-N-([4-(methylamino)-6-[(1-methylethyl)sulfanyl]-1,3,5-triazin-2-yl]carbamoyl)benzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-chloro-N-[[4-(ethylsulfanyl)-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-(ethylsulfanyl)-6-methoxy-1,3,5-triazin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-(ethylsulfanyl)-6-methylpyrimidin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-(methylamino)-6-(methylsulfanyl)-1,3,5-triazin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-methoxy-6-(methylsulfanyl)pyrimidin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-methoxy-6-(propylsulfanyl)-1,3,5-triazin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-chloro-N-[[4-methyl-6-(propylsulfanyl)pyrimidin-2-yl]carbamoyl]benzenesulfonamide
-
-
2-ethoxy-2-oxoethyl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methyl[1,1'-biphenyl]-2-carboxylate
-
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
2-methoxy-2-oxoethyl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methyl[1,1'-biphenyl]-2-carboxylate
-
2-nitro-5-(phenylsulfonyl)phenyl 4-chlorobenzoate
-
2-oxoisovalerate
competitive
2-phenyl-3-[[3-(trifluoromethyl)benzoyl]oxy]quinazolin-4(3H)-one
-
2-phenyl-3-{[3-(trifluoromethyl)benzoyl]oxy}quinazolin-4-one
-
2-substituted-8-(4,6-dimethoxypyrimidin-2-yloxy)-4-methylphthalazin-1-one derivatives
-
synthesis of diverse derivatives and inhibitory potency, overview
-
2-[(2-chloroethoxy)methyl]-N-[(4-chloropyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-[(2-chloroethoxy)methyl]-N-[(4-methylpyrimidin-2-yl)carbamoyl]benzenesulfonamide
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(2-fluoro-3-methylphenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(2-fluoro-4-methylphenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(2-fluoro-5-methylphenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(2-fluorophenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(3-fluorophenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(3-methylphenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(4-fluorophenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(4-methylphenoxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-(naphthalen-2-yloxy)benzoic acid
-
-
2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]-6-phenoxybenzoic acid
-
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-3-fluorobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-3-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methyl-6-(5-methylpyridin-3-yl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methyl-6-(naphthalen-2-yl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methyl-6-(pyridin-3-yl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methyl-6-(pyrimidin-5-yl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-(methylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-ethylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-ethynylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-fluorobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-hydroxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-iodobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-nitrobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(1-methylethoxy)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(1H-pyrrol-1-yl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(2-methoxypyrimidin-5-yl)-4-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(6-fluoropyridin-3-yl)-4-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(ethylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(furan-2-yl)-4-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(furan-3-yl)-4-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(methylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(methylsulfonyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(phenylcarbonyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(propylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-(trifluoromethoxy)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-ethoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-ethylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-fluorobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-iodobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-methoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-nitrobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-phenoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-propoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-propylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(1-methylethoxy)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(ethylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(methylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(phenylcarbonyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(propylsulfanyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-(trifluoromethyl)benzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-ethoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-fluorobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-iodobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-methoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-methylbenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-nitrobenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-phenoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]-6-propoxybenzoic acid
-
2-[(4,6-dimethoxypyrimidin-2-yl)sulfanyl]benzoic acid
-
2-[([1,1'-biphenyl]-4-yl)oxy]-6-[(4,6-dimethoxy-1,3,5-triazin-2-yl)oxy]benzoic acid
-
-
2-[[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl]-N,N-dimethylbenzamide
-
-
3'-chloro-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylic acid
-
3-(7H-cyclopenta[b]pyridin-5-yl)-N-[(2-nitrophenyl)sulfanyl]alanine
-
inhibition profile and inhibition of root growth, overview
3-Bromopyruvate
-
competitive to 2-oxobutanoate
3-phosphoglycerate
-
noncompetitive
3-[(3-bromobenzoyl)oxy]-2-phenylquinazolin-4(3H)-one
-
3-[(3-bromobenzoyl)oxy]-2-phenylquinazolin-4-one
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-2'-fluoro-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-3',5'-difluoro-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-3'-fluoro-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4',5-dimethylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4'-fluoro-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4'-methoxy-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-fluorobiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methoxybiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methyl-4'-nitrobiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylic acid
3-[(4-nitrobenzoyl)oxy]quinazolin-4(3H)-one
-
3-[(4-nitrobenzoyl)oxy]quinazolin-4-one
-
4'-bromo-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylic acid
-
4'-chloro-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methoxybiphenyl-2-carboxylic acid
-
4'-chloro-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylic acid
-
4-(cyclopropylcarbonyl)-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-1-methyl-1H-pyrazole-5-sulfonamide
-
i.e. K13030
4-acetyl-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-1-methyl-1H-pyrazole-5-sulfonamide
-
i.e. K13010
4-oxo-2-m-tolylquinazolin-3(4H)-yl 3-fluorobenzoate
-
9.5% inhibition at 0.1 mM
4-oxo-2-m-tolylquinazolin-3(4H)-yl 3-methylbenzoate
-
10.5% inhibition at 0.1 mM
4-oxo-2-m-tolylquinazolin-3(4H)-yl 4-chlorobenzoate
-
no inhibition at 0.1 mM
4-oxo-2-m-tolylquinazolin-3(4H)-yl 4-methylbenzoate
-
33% inhibition at 0.1 mM
4-oxo-2-m-tolylquinazolin-3(4H)-yl benzoate
-
40.5% inhibition at 0.1 mM
4-oxo-2-m-tolylquinazolin-3(4H)-yl-3-(trifluoromethyl)benzoate
-
9.5% inhibition at 0.1 mM
4-oxo-2-o-tolylquinazolin-3(4H)-yl 3-fluorobenzoate
-
30% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 2-methylbenzoate
-
16.5% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 3-chlorobenzoate
-
80.5% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 3-fluorobenzoate
-
26% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 3-methoxybenzoate
-
27% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 3-methylbenzoate
-
4% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 3-nitrobenzoate
-
91.5% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 4-chlorobenzoate
-
7.5% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl 4-methylbenzoate
-
18% inhibition at 0.1 mM
4-oxo-2-phenylquinazolin-3(4H)-yl benzoate
-
20.5% inhibition at 0.1 mM
5-amino-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
5-benzyl-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
5-bromo-2-([[(2-chlorophenyl)sulfonyl]carbamoyl]amino)pyrimidin-4-yl benzoate
-
-
5-bromo-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
5-chloro-1-(4-chlorophenyl)-3-methyl-N-((4-(trifluoromethoxy)phenyl)sulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-chlorophenyl)-3-methyl-N-(phenylsulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-chlorophenyl)-3-methyl-N-tosyl-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-3-methyl-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-chlorophenyl)-N-((4-methoxyphenyl)-sulfonyl)-3-methyl-1H-pyrazole-4-carboxamide
73% inhibition at 100 mg/l
5-chloro-1-(4-fluorophenyl)-3-methyl-N-((4-(trifluoromethoxy)phenyl)sulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-fluorophenyl)-3-methyl-N-(phenylsulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-fluorophenyl)-3-methyl-N-tosyl-1H-pyrazole-4-carboxamide
-
5-chloro-1-(4-fluorophenyl)-N-((4-methoxyphenyl)-sulfonyl)-3-methyl-1H-pyrazole-4-carboxamide
-
5-chloro-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
5-chloro-3-methyl-1-(p-tolyl)-N-((4-(trifluoromethoxy)-phenyl)sulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-3-methyl-1-(p-tolyl)-N-tosyl-1H-pyrazole-4-carboxamide
-
5-chloro-3-methyl-1-phenyl-N-((4-(trifluoromethoxy)phenyl)-sulfonyl)-1H-pyrazole-4-carboxamide
81% inhibition at 100 mg/l
5-chloro-3-methyl-1-phenyl-N-(phenylsulfonyl)-1H-pyrazole-4-carboxamide
-
5-chloro-3-methyl-1-phenyl-N-tosyl-1H-pyrazole-4-carboxamide
-
5-chloro-3-methyl-N-(phenylsulfonyl)-1-(p-tolyl)-1H-pyrazole-4-carboxamide
-
5-chloro-3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylic acid
-
5-chloro-N-((4-chlorophenyl)sulfonyl)-1-(4-fluorophenyl)-3-methyl-1H-pyrazole-4-carboxamide
-
5-chloro-N-((4-chlorophenyl)sulfonyl)-3-methyl-1-(p-tolyl)-1H-pyrazole-4-carboxamide
-
5-chloro-N-((4-chlorophenyl)sulfonyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide
65% inhibition at 100 mg/l
5-chloro-N-((4-methoxyphenyl)sulfonyl)-3-methyl-1-(p-tolyl)-1H-pyrazole-4-carboxamide
-
5-chloro-N-((4-methoxyphenyl)sulfonyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide
-
5-cyano-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
-
6,6'-disulfanediyldipyridine-3-carboxylic acid
-
inhibition profile and inhibition of root growth, overview
8-(4,6-dimethoxypyrimidin-2-yloxy)-4-methylphthalazin-1(2H)-one
-
-
8-[(4,6-dimethoxypyrimidin-2-yl)oxy]-4-methylphthalazin-1(2H)-one
-
Ag+
-
0.1 mM, 98% residual activity
bensulfuron-methyl
a sulfonylurea herbicide; mutant W548L/S627I, 22% inhibition at 0.1 nM
benzaldehyde
-
inhibits isozyme AHAS II, not isozyme AHAS I
branched-chain amino acids
-
feedback inhibition, differential inhibition of isozymes, overview
-
chlorimuron-ethyl
-
binding conformation
chlorimuronethyl
-
noncompetitive, lowest total interaction energy and highest MolDock score of 140054 kcal/mol and -141.52, respectively, of the compounds analyzed
Co2+
-
0.1 mM, 44% residual activity
ethyl 2-([(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl)benzoate
-
compound binds within a pocket of the enzyme formed by amino acid residues Met351, Asp375, Arg377, Gly509, Met570 and Val571
ethyl 2-([(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl)benzoate
-
compound binds within a pocket of the enzyme formed by amino acid residues Met351, Asp375, Arg377, Gly509, Met570 and Val571
ethyl 2-([[5-bromo-4-(bromomethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
ethyl 2-([[5-bromo-4-(ethoxymethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
ethyl 2-([[5-bromo-4-(methoxymethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
ethyl 2-[(pyrimidin-2-ylcarbamoyl)sulfamoyl]benzoate
-
-
ethyl 2-[([4-[(acryloyloxy)methyl]-5-bromopyrimidin-2-yl]carbamoyl)sulfamoyl]benzoate
-
-
ethyl 2-[[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(4,6-dimethylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(4-chloro-6-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(5-bromo-4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(5-bromo-4,6-dimethylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 2-[[(5-bromo-4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
ethyl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methyl[1,1'-biphenyl]-2-carboxylate
-
ethyl 4-chloro-2-[[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
FAD
-
0.01 mM, 92% inhibition
glyoxylate
-
isozyme AHAS II
Hg2+
-
0.1 mM, 43% residual activity
Hydroxypyruvate
-
progressive inactivation of enzyme with kinetics of suicide inhibition, mechanism
KIH-6127
-
i.e. pyriminobac-methyl
L-2-aminobutanoate
-
5 mM, 21% inhibition
L-Thr
-
5 mM, 6.6% inhibition
methyl 2-([(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl)benzoate
-
methyl 2-([[4-(ethylsulfanyl)-6-methoxypyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-(methylamino)-6-(propylsulfanyl)-1,3,5-triazin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-chloro-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-chloro-6-(methylsulfanyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-methoxy-6-(methylsulfanyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[4-methoxy-6-(propylsulfanyl)-1,3,5-triazin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[5-bromo-4-(bromomethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[5-bromo-4-(dibromomethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[5-bromo-4-(ethoxymethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-([[5-bromo-4-(methoxymethyl)pyrimidin-2-yl]carbamoyl]sulfamoyl)benzoate
-
-
methyl 2-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
methyl 2-[[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
methyl 2-[[(5-bromo-4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
-
methyl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylate
-
methyl 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylate
-
methyl-2-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoate
-
Mg2+
-
0.5 mM, 80% residual activity
N-(4,6-dimethylpyrimidin-2-yl)-5-methyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[e][1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
N-([4-[(benzyloxy)methyl]-5-bromopyrimidin-2-yl]carbamoyl)-2-chlorobenzenesulfonamide
-
-
N-([5-bromo-4-[(prop-2-en-1-yloxy)methyl]pyrimidin-2-yl]carbamoyl)-2-(2-chloroethoxy)benzenesulfonamide
-
-
N-phenyl-3-(phenyldisulfanyl)-1H-1,2,4-triazole-1-carboxamide
strong inhibition
N-phthalyl-L-isoleucine anilide
50% inhibition at 0.1 mM, crude enzyme preparation
N-phthalyl-L-phenylalanine anilide
50% inhibition at 0.047 mM, crude enzyme preparation
N-phthalyl-L-valine anilide
50% inhibition at 0.0023 mM, crude enzyme preparation
N-phthalyl-L-valine-anilide
-
and related compounds
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-(ethylsulfanyl)-6-(2-fluoro-1-hydroxyethyl)benzenesulfonamide
-
i.e. K12147
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
N-[(5-bromo-4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-chlorobenzenesulfonamide
-
-
N-[(5-bromo-4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(5-bromo-4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[(5-bromo-4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(5-bromo-4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[(5-bromo-4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-2-chlorobenzenesulfonamide
-
-
N-[(5-bromo-4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[(5-bromo-4-methoxypyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(5-bromo-4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[(5-bromopyrimidin-2-yl)carbamoyl]-2-chlorobenzenesulfonamide
-
-
N-[[(4-methoxy-1,3,5-triazin-2-yl)amino]carbonyl]-1-phenylmethanesulfonamide - methyl hydroperoxide
N-[[5-bromo-4-(1-methylethoxy)pyrimidin-2-yl]carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[[5-bromo-4-(bromomethyl)pyrimidin-2-yl]carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[[5-bromo-4-(bromomethyl)pyrimidin-2-yl]carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[[5-bromo-4-(dibromomethyl)pyrimidin-2-yl]carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[[5-bromo-4-(dibromomethyl)pyrimidin-2-yl]carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[[5-bromo-4-(ethenyloxy)pyrimidin-2-yl]carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[[5-bromo-4-(ethoxymethyl)pyrimidin-2-yl]carbamoyl]-2-chlorobenzenesulfonamide
-
-
N-[[5-bromo-4-(ethoxymethyl)pyrimidin-2-yl]carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[[5-bromo-4-(methoxymethyl)pyrimidin-2-yl]carbamoyl]-2-chlorobenzenesulfonamide
-
-
N-[[5-bromo-4-(methoxymethyl)pyrimidin-2-yl]carbamoyl]-2-[(2-chloroethoxy)methyl]benzenesulfonamide
-
-
N-[[5-bromo-4-(tribromomethyl)pyrimidin-2-yl]carbamoyl]-2-nitrobenzenesulfonamide
-
-
NADP+
-
0.01 mM, 63% inhibition
NADPH
-
0.01 mM, 100% inhibition
phosphate
-
inhibits activity of enzyme assayed in acetate buffer
phosphoenolpyruvate
-
noncompetitive
primisulfuron methyl
-
IC50: 0.0042 mM, over 80% inhibition at 0.04 mM
primisulfuron-methyl
-
1 mM, 50% inhibition
propan-2-yl 4-bromo-3-[[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl]benzoate
-
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
pyrazosulfuron-ethyl
a sulfonylurea herbicide
pyrimidinyl-(thio) benzoates
pyrimidinylthiobenzoate
-
pyrimidylsalicylate
-
0.025 mM, 60% inhibition
pyriminobac
a pyrimidinylcarboxylate herbicide; mutant W548L/S627I, 13% inhibition at 0.1 nM
pyriminobac-methyl
herbicide-resistant enzyme variant from Pseudomonas sp. Lm10 shows 9.2fold higher resistance than the sensitive variant from Pseudomonas putida KT2440
pyrithiobac sodium
inhibitor of wild-type enzyme, poor inhibition of the P197E mutant enzyme
pyrithiobac-sodium
a pyrimidinylcarboxylate herbicide; mutant W548L/S627I, 32% inhibition at 0.1 nM
SO42-
-
competitive when assayed in phosphate buffer, mixed type, when assayed in acetate buffer
sodium 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]-5-methylbiphenyl-2-carboxylate
-
sodium 3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylate
-
sulfonylaminocarbonyltriazolinone
-
thiamine thiazolone diphosphate
-
-
thifensulfuron-methyl
-
-
triasulfuron
-
21 out of 27 isolated bacteria in pure culture are inhibited by triasulfuron, the addition of isoleucine and/or valine reverses the effect in 19 cases
tribenuron
inhibitor of wild-type enzyme, poor inhibition of the P197E mutant enzyme
triflusulfuron methyl
-
1 mM, 50% inhibition
[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
[5-bromo-2-[([[2-(1-methoxyethenyl)phenyl]sulfonyl]carbamoyl)amino]pyrimidin-4-yl]methyl prop-2-enoate
-
-
2-(5-ethyl-3-methylpyridin-2-yl)-5-isopropyl-5-methyl-3,5-dihydro-4H-imidazol-4-one
-
wild-type, 50% inhibition at 0.00318 mM, mutant C411S, 50% inhibition at 0.00426 mM, mutant C607S, 50% inhibition at 0.00099 mM
2-(5-ethyl-3-methylpyridin-2-yl)-5-isopropyl-5-methyl-3,5-dihydro-4H-imidazol-4-one
-
i.e. Cadre
2-(5-ethyl-3-methylpyridin-2-yl)-5-isopropyl-5-methyl-3,5-dihydro-4H-imidazol-4-one
-
-
2-(5-ethyl-3-methylpyridin-2-yl)-5-isopropyl-5-methyl-3,5-dihydro-4H-imidazol-4-one
-
i.e. Cadre
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
67.5% inhibition at 10 mg/l
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
68.9% inhibition at 10 mg/l
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
64.8% inhibition at 10 mg/l
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-bromo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
69.9% inhibition at 10 mg/l
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
68.2% inhibition at 10 mg/l
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
62.2% inhibition at 10 mg/l
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
64.1% inhibition at 10 mg/l
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
62.2% inhibition at 10 mg/l
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
67.7% inhibition at 10 mg/l
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-chloro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
44.5% inhibition at 10 mg/l
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
67.9% inhibition at 10 mg/l
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
72.6% inhibition at 10 mg/l
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-fluoro-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
68.9% inhibition at 10 mg/l
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methoxy-6-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
68.5% inhibition at 10 mg/l
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-iodo-N-[(4-methylpyrimidin-2-yl)carbamoyl]-6-nitrobenzenesulfonamide
-
-
2-oxobutanoate
-
isoenzyme I has lower sensitivity to inhibition than isoenzyme III
2-oxobutanoate
-
inhibits formation of acetolactate from pyruvate
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylic acid
-
3-[(4,6-dimethoxypyrimidin-2-yl)oxy]biphenyl-2-carboxylic acid
-
bensulfuron
-
bispyribac
-
bispyribac
about 58% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1
bispyribac-sodium
-
bispyribac-sodium
almost no effect on the mutant W548L/S627I even at 100 mM, which is an approximately 10000fold higher concentration than the concentration required for 50% inhibition of the wild-type; a pyrimidinylcarboxylate herbicide
bispyribac-sodium
a pyrimidinyl carboxy herbicide
Cadre
-
an imidazolinone herbicide
Cadre
-
an imidazole herbicide, no inhibition of mutant R372S/F373P/D374V/D375E/R376Y
Cadre
-
an imidazole herbicide, wild-type enzyme IC50: 0.0041 mM
Cadre
-
imidazolinone inhibitor
chlorimuron ethyl
-
a sulfonylurea herbicide, complex inhibition, binding structure, overview
chlorimuron ethyl
about 90% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1
chlorimuron ethyl
-
a sulfonylurea herbicide, complex inhibition, overview
chlorimuron ethyl
-
a sulfonylurea herbicide
chlorimuron ethyl
a sulfonylurea herbicide, complex inhibition, overview
chlorimuron ethyl
-
a sulfonylurea herbicide, complex inhibition, overview
chlorimuron ethyl
-
IC50: 0.009 mM, over 80% inhibition at 0.04 mM
chlorimuron ethyl
a sulfonylurea derivative herbicide
chlorimuron ethyl
-
a sulfonylurea herbicide, complex inhibition, overview
chlorsulfuron
-
-
chlorsulfuron
a sulfonylurea herbicide
chlorsulphuron
-
-
chlorsulphuron
-
inhibition of the enzyme from Arabidopsis thaliana and of the enzyme expressed in E. coli
EDTA
-
dialysis against EDTA leads to an irreversible loss of activity
EDTA
-
20 mM, no residual activity
florasulam
-
florasulam
inhibitor of wild-type enzyme, poor inhibition of the P197E mutant enzyme
flucarbazone
-
flumetsulam
-
-
flumetsulam
herbicide-resistant enzyme variant from Pseudomonas sp. Lm10 shows 6.5fold higher resistance than the sensitive variant from Pseudomonas putida KT2440
foramsulfuron
-
Ile
-
insensitive to
Ile
-
mild inhibition of isoenzyme I and III
Ile
-
isoenzyme AHS I is sensitive to feed-back inhibition, isoenzyme AHS II is insensitive
Ile
-
5 mM, 32% inhibition
Ile
-
inhibition of isoenzyme I, no inhibition of isoenzyme II
Ile
-
less potent, noncompetitive
Ile
-
1 mM, 50% inhibition
Ile
-
enzyme form AHS I is inhibited. Enzyme form AHS II is not inhibited
imazamox
-
imazapyr
-
-
imazapyr
-
an imidazolinone herbicide, complex inhibition, overview
imazapyr
-
an imidazolinone herbicide, complex inhibition, overview
imazapyr
-
an imidazolinone herbicide
imazapyr
an imidazolinone herbicide, complex inhibition, overview
imazapyr
-
an imidazolinone herbicide, complex inhibition, overview
imazapyr
-
i.e. 2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid
imazapyr
-
a imidazolinone herbicide, complex inhibition, overview
imazapyr
an imidazolinon herbicide; mutant W548L/S627I, 27% inhibition at 0.1 nM
imazapyr
-
enzyme form AHS I and AHS II
imazapyr
-
slow, tight-binding inhibitor
imazaquin
-
an imidazolinone herbicide, complex inhibition, binding structure, overview
imazaquin
about 20% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1, about 85% enzyme inhibition after 2 days at enzyme:inhibitor ratio of 1000:1
imazaquin
-
uncompetitive
imazaquin
-
an imidazolinone herbicide, complex inhibition, overview
imazaquin
an imidazolinone herbicide, complex inhibition, overview
imazaquin
-
an imidazolinone herbicide, complex inhibition, overview
imazaquin
-
a imidazolinone herbicide, complex inhibition, overview
imazaquin
an imidazolinon herbicide
imazaquin
-
1 mM, 50% inhibition
imazethapyr
-
imazethapyr
inhibitor of wild-type enzyme, poor inhibition of the P197E mutant enzyme
imazethapyr
herbicide-resistant enzyme variant from Pseudomonas sp. Lm10 shows 12.6fold higher resistance than the sensitive variant from Pseudomonas putida KT2440
imazosulfuron
a sulfonylurea herbicide
imazosulfuron
-
sulfonylurea-resistant biotype, 50% inhibition above 3000 nM, sulfonylurea-susceptible biotype, 50% inhibition at 15 nM
imazosulfuron
60-80% inhibition at 0.1-100 mM imazosulfuron; no or poor inhibition of resistant mutant enzyme, IC50 values in different plant accessions, overview; no or poor inhibition of resistant mutant enzyme, IC50 values in different plant accessions, overview
imidazolinone
-
imidazolinones
-
the imidazolinones behave as non-competitive or uncompetitive inhibitors
isoleucine
-
feedback inhibition of wild-type enzyme about 50% at 10 mM, M8 and M13 mutants are resistant
isoleucine
feedback inhibition; feedback inhibition; feedback inhibition
isoleucine
feedback inhibition
isoleucine
-
feedback inhibition
isoleucine
-
feedback inhibition
isoleucine
-
feedback inhibition
isoleucine
-
1 mM, about 90% residual activity in both sulfonylurea-susceptible and sulfonylurea-resistant biotype
isoniazid
-
-
K12147
-
-
K13010
-
-
K13030
-
-
KHG20612
-
KHG20612
-
inhibition kinetics and antimycobacterial activity, overview
KHG20612
strong inhibition
L-isoleucine
-
-
L-leucine
-
-
L-valine
-
-
L-valine
-
inhibits to a maximal activity of approximately 50% at concentrations higher than 0.5 mM
L-valine
-
not inhibitory for catalytic subunit alone, inhibitory for catalytic subunit plus small subunit
L-valine
50% inhibition at 20 mM, crude enzyme preparation
Leu
-
insensitive to
Leu
-
inhibition of the enzyme from Arabidopsis thaliana, no inhibition of the enzyme expressed in E. coli
Leu
-
mixed noncompetitive inhibition of isoenzyme, pH-independent inhibition of isoenzyme III
Leu
-
no inhibition of isoenzyme I and III
Leu
-
isoenzyme AHS I is sensitive to feed-back inhibition, isoenzyme AHS II is insensitive
Leu
-
5 mM, 23% inhibition
Leu
-
inhibition of isoenzyme I, no inhibition of isoenzyme II
Leu
-
1 mM, 50% inhibition
Leu
-
enzyme form AHS I is inhibited. Enzyme form AHS II is not inhibited
Leu
-
cooperative effect with Val
leucine
-
feedback inhibition
leucine
-
feedback inhibition
leucine
-
feedback inhibition of wild-type enzyme about 50% at 10 mM, M8 and M13 mutants are resistant
leucine
-
feedback inhibition
leucine
feedback inhibition; feedback inhibition; feedback inhibition
leucine
feedback inhibition
leucine
-
feedback inhibition
leucine
feedback inhibition
leucine
-
feedback inhibition
leucine
-
feedback inhibition
leucine
-
feedback inhibition
leucine
feedback inhibition
leucine
-
feedback inhibition
leucine
-
feedback inhibition
leucine
-
1 mM, about 50% residual activity in both sulfonylurea-susceptible and sulfonylurea-resistant biotype
leucine
-
feedback inhibition
Londax
-
a sulfonylurea herbicide
Londax
-
a sulfonylurea herbicide, no inhibition of mutant R372S/F373P/D374V/D375E/R376Y
Londax
-
a sulfonylurea herbicide, wild-type enzyme IC50: 0.013 mM
mesosulfuron
-
metosulam
-
metsulfuron methyl
-
a sulfonylurea herbicide, complex inhibition, overview
metsulfuron methyl
-
a sulfonylurea herbicide, complex inhibition, overview
metsulfuron methyl
a sulfonylurea herbicide, complex inhibition, overview
metsulfuron methyl
-
a sulfonylurea herbicide, complex inhibition, overview
metsulfuron methyl
-
IC50: 0.006 mM, over 80% inhibition at 0.04 mM
metsulfuron methyl
-
a sulfonylurea herbicide, complex inhibition, overview
metsulfuron-methyl
-
-
metsulfuron-methyl
herbicide-resistant enzyme variant from Pseudomonas sp. Lm10 shows 56fold higher resistance than the sensitive variant from Pseudomonas putida KT2440
Mn2+
-
0.5 mM, 28% residual activity
Mn2+
-
activates, high concentrations inhibit
monosulfuron
-
-
monosulfuron
93% inhibition at 100 mg/l
N-(4,6-dimethylpyrimidin-2-yl)-5-methyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[e][1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
-
wild-type, 50% inhibition at 0.00262 mM, mutant C411S, 50% inhibition at 0.00668 mM, mutant C607S, 50% inhibition at 0.00887 mM
N-(4,6-dimethylpyrimidin-2-yl)-5-methyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[e][1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
-
i.e. TP
N-(4,6-dimethylpyrimidin-2-yl)-5-methyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[e][1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
-
68.4% inhibition at 10 mg/l
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-fluoro-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
-
65.1% inhibition at 10 mg/l
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-2-iodo-6-nitrobenzenesulfonamide
-
-
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
-
-
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
-
65.1% inhibition at 10 mg/l
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
-
-
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
-
-
N-[(4,6-dimethylpyrimidin-2-yl)carbamoyl]-2-nitro-6-(2,2,2-trifluoroethoxy)benzenesulfonamide
-
-
N-[(4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
N-[(4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide
-
-
N-[[(4-methoxy-1,3,5-triazin-2-yl)amino]carbonyl]-1-phenylmethanesulfonamide - methyl hydroperoxide
-
ratio 1:1, i.e. Londax
N-[[(4-methoxy-1,3,5-triazin-2-yl)amino]carbonyl]-1-phenylmethanesulfonamide - methyl hydroperoxide
-
ratio 1:1
N-[[(4-methoxy-1,3,5-triazin-2-yl)amino]carbonyl]-1-phenylmethanesulfonamide - methyl hydroperoxide
-
ratio 1:1, i.e. Londax
NC-311
-
NC-311
-
sulfonylurea derivative, wild-type, 50% inhibition at 9.39 nM, mutant C411S, 50% inhibition at 16.83 nM, mutant C607S, 50% inhibition at 20.25 nM
NC-311
-
sulfonylurea inhibitor
nicosulfuron
-
PCMB
-
-
penoxsulam
-
penoxsulam
95% inhibition after 40 min at 0.002 mM
primisulfuron
-
propoxycarbazone
-
propoxycarbazone
about 55% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
-
i.e. ZJ0273. Moderate susceptibility of plants
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
-
i.e.ZJ0273
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
-
i.e. ZJ0273. ALS activity in vivo is hardly affected by ZJ0273 at 100 mg/l
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
-
i.e. ZJ0273. Decline of ALS activity and lower biomass production at a rate of 10 mg/l of ZJ0273
propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate
Malachium aquaticum
-
i.e. ZJ0273. Moderate susceptibility of plants
prosulfuron
-
pyrazosulfuron ethyl
-
-
pyrazosulfuron ethyl
-
IC50: 87 nM, over 80% inhibition at 0.04 mM
pyrazosulfuron ethyl
-
IC50: 870 nM
pyriftalid
-
-
pyrimidinyl-(thio) benzoates
-
pyrimidinyl-(thio) benzoates
-
pyrithiobac
-
pyrithiobac
about 70% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1
pyroxsulam
-
pyroxsulam
inhibitor of wild-type enzyme, poor inhibition of the P197E mutant enzyme
rifampicin
-
-
sucrose
-
-
sulfometuron methyl
-
-
sulfometuron methyl
-
the enzyme inhibitor shows activity against Mycobacterium tuberculosis both in vitro and in vivo
sulfometuron methyl
-
the enzyme inhibitor shows activity against Mycobacterium tuberculosis both in vitro and in vivo
sulfometuron methyl
-
IC50: 0.0048 mM, over 80% inhibition at 0.04 mM
sulfometuron methyl
-
active against Mycobacterium tuberculosis both in vitro and in vivo
sulfometuron methyl
-
the enzyme inhibitor shows activity against Mycobacterium tuberculosis both in vitro and in vivo
sulfometuron-methyl
-
-
sulfometuron-methyl
-
2.5 mM, 50% inhibition
sulfometuron-methyl
-
enzyme form AHS I and AHS II
sulfonylurea
-
the inhibition by sulfonylurea is non-competitive or nearly competitive with respect to pyruvate
sulfonylurea
-
potently inhibiting herbicide
thiencarbazone
-
thiencarbazone methyl
-
thiencarbazone methyl
about 40% enzyme inhibition after 2 h at enzyme:inhibitor ratio of 10:1
thiencarbazone methyl
-
-
thiencarbazone methyl
94% inhibition after 60 min at 0.002 mM
tribenuron methyl
-
-
tribenuron-methyl
-
-
trifloxysulfuron
-
tritosulfuron
-
Val
-
no inhibition
Val
-
inhibition of the enzyme from Arabidopsis thaliana, no inhibition of the enzyme expressed in E. coli
Val
-
competitive; feed-back inhibition
Val
-
isoenzymes I and II are inhibited, isoenzyme II is not inhibited
Val
-
isoenzyme I and III inhibited
Val
-
isoenzyme I is more resistant to inhibition than isoenzyme III
Val
-
isoenzyme AHS I is sensitive to feed-back inhibition, isoenzyme AHS II is insensitive
Val
-
5 mM, 89% inhibition; feed-back inhibition; noncompetitive
Val
-
feed-back inhibition
Val
-
feed-back inhibition
Val
-
feed-back inhibition
Val
-
noncompetitive; pH-dependent inhibition
Val
-
isoenzymes I and II are inhibited, isoenzyme II is not inhibited
Val
-
two enzyme forms: one is very sensitive to inhibition by Val, the second is not subject to feedback inhibition
Val
-
feed-back inhibition; noncompetitive
Val
-
0.1 mM, 50% inhibition
Val
-
feed-back inhibition; noncompetitive
Val
-
enzyme form AHS I is inhibited. Enzyme form AHS II is not inhibited
Val
-
cooperative effective with Leu
valine
-
feedback inhibition
valine
-
feedback inhibition
valine
-
feedback inhibition of wild-type enzyme about 50% at 10 mM, M8 and M13 mutants are resistant
valine
-
isozyme AHAS I, feedback inhibition
valine
-
isozyme AHAS I, cooperative feedback inhibition
valine
-
binding site structure, inhibition mechanism
valine
-
feedback inhibition
valine
feedback inhibition; feedback inhibition; feedback inhibition
valine
feedback inhibition
valine
-
feedback inhibition
valine
feedback inhibition
valine
-
feedback inhibition
valine
-
feedback inhibition
valine
-
feedback inhibition
valine
-
feedback inhibition, reversible by MgATP2-
valine
feedback inhibition, the inhibition by valine is uniquely in fungi reversed by MgATP
valine
-
feedback inhibition
valine
-
feedback inhibition
valine
-
1 mM, about 70%% residual activity in sulfonylurea-susceptible and 80% in sulfonylurea-resistant biotype
valine
-
feedback inhibition
[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
-
a triazolopyrimidine derivative herbicide, no inhibition of mutant R372S/F373P/D374V/D375E/R376Y
[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
-
a triazolopyrimidine derivative herbicide, wild-type enzyme IC50: 0.0293 mM
additional information
-
ligand binding structures, and inhibition mechanism, overview
-
additional information
-
AHAS from Bacillus anthracis shows strong resistance to three classes of herbicides, the sulfonylurea Londax, the imidazolinone Cadre, and the triazolopyrimidine TP
-
additional information
-
ligand binding structures, and inhibition mechanism, overview
-
additional information
-
computational database screening for non-sulfonylurea inhibitors of AHAS, overview
-
additional information
-
inhibition kinetics or recombinant wild.type and reconstituted isozymes AHAS I
-
additional information
-
isozyme AHAS II is not feedback inhibited
-
additional information
-
inhibitor synthesis, overview. Determination of ligand-receptor interaction and resistance mechanism in AHAS-sulfonylurea herbicide system, molecular modeling, overview
-
additional information
-
bulky substitutions in ortho-position of the sulfamoyl group in N-[(4-chloropyrimidin-2-yl)carbamoyl]benzenesulfonamide may enhance inhibitory activity. Negative charge distributed over a large surface area may enhance this activity. For better activity, the number of electronegative atoms present in the molecule should be high
-
additional information
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern
-
additional information
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern
-
additional information
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern; feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme. Certain imidazolinones show significant activity against the bacterial enzyme with Ki values of below 0.11 mM. Molecular docking of benzoyl ester compounds. AHAS-inhibitors and the probable binding pattern
-
additional information
ligand binding structures, and inhibition mechanism, overview
-
additional information
inhibitor library screening
-
additional information
-
inhibitor library screening
-
additional information
-
leucine had negligible effect on the activity
-
additional information
-
ligand binding structures, and inhibition mechanism, overview
-
additional information
-
no effect: Mg2+
-
additional information
-
no effect: Mn2+, Mg2+, Ca2+
-
additional information
-
screening of 100 sulfonylurea analogues for antimycobacterial activity, minimal inhibitory concentrations, overview
-
additional information
-
screening of 100 sulfonylurea analogues for antimycobacterial activity, minimal inhibitory concentrations, overview
-
additional information
-
mechanism and potency of enzyme inhibition by sulfonylurea herbicides, overview
-
additional information
-
screening of chemical libraries for effective inhibitors of the enzyme, overview
-
additional information
-
screening of 100 sulfonylurea analogues for antimycobacterial activity, minimal inhibitory concentrations, overview
-
additional information
-
not inhibited by bensulfuron methyl
-
additional information
not inhibited by bensulfuron methyl
-
additional information
-
single stranded DNA aptamers Apt1 (CGAGTGAGGGCGAGGCGCGCTCCTGCCGGT) and Apt6 (CGGCCAGGGGACGAGCGCGCCCTGATCGTG) demonstrate the greatest inhibitory potential against the enzyme activity with IC50 values in the low nanomolar range (28.94 and 22.35 nM respectively). Aptamers Apt2, Apt3 and Apt4 show moderate to lower inhibition specificities
-
additional information
-
screening of 100 sulfonylurea analogues for antimycobacterial activity, minimal inhibitory concentrations, overview
-
additional information
-
enzyme mutation P197E causes chick weed plant resistance to ALS inhibitors in population WRR04
-
additional information
enzyme mutation P197E causes chick weed plant resistance to ALS inhibitors in population WRR04
-
additional information
-
IC50 values of herbicides with mutant enzymes, overview
-
additional information
-
ligand binding structures, and inhibition mechanism, overview
-
additional information
-
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme
-
additional information
molecular docking of inhibitor molecules to the enzyme crystal structure, 3D-QSAR modeling, overview
-
additional information
-
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme
-
additional information
-
feedback inhibition takes place in the holoenzyme containing the regulatory and the catalytic subunits. The branched-chain amino acids are believed to bind only to the regulatory subunit and inhibit the enzyme
-
additional information
-
the majority of soil bacteria contain only one functional acetohydroxyacid synthase enzyme sensitive to sulfonylurea herbicides
-
additional information
no inhibition by N-phthalyl-L-leucine, N-phthalyl-L-norleucine, N-phthalyl-L-phenylglycine, N-phthalyl-L-norvaline, N-phthalyl-L-glycine, N-phthalyl-L-alanine, crude enzyme preparation
-